AI assistant
Sending…
Health Catalyst, Inc. — Director's Dealing 2019
Jul 30, 2019
33681_dirs_2019-07-29_64d15531-40ca-44ea-aa76-a2ba7eb13689.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2019-07-29
Reporting Person: KANE JOHN A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-29 | Common Stock | C | 23586 | — | Acquired | 80877 | Direct |
| 2019-07-29 | Common Stock | C | 589 | — | Acquired | 81466 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-07-29 | Series E Preferred Stock | $ | C | 23586 | Disposed | Common Stock (23586.0) | Direct | |
| 2019-07-29 | Series F Preferred Stock | $ | C | 589 | Disposed | Common Stock (589.0) | Direct |
Footnotes
F1: Each share of Series E Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.
F2: Each share of Series F Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.
More from Health Catalyst, Inc.
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 20
Regulatory Filings
2026
Feb 18
Regulatory Filings
2026
Jan 23